Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell Carcinomas

NCT03189186 is registered in ClinicalTrials.gov with University of California, Irvine as lead sponsor.

NCT NCT03189186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03189186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell Carcinomas
Lead sponsor
University of California, Irvine
Phase
Phase 1
Overall status
Withdrawn
Start date
July 1, 2017
Completion date
October 17, 2018
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic kidney cancer, renal cell carcinoma